In the last trading session, 1.65 million Precigen Inc (NASDAQ:PGEN) shares changed hands as the company’s beta touched 1.82. With the company’s per share price at $1.41 changed hands at $0.05 or 3.68% during last session, the market valuation stood at $416.20M. PGEN’s last price was a discount, traded about -53.9% off its 52-week high of $2.17. The share price had its 52-week low at $0.65, which suggests the last value was 53.9% up since then.
Analysts gave the Precigen Inc (PGEN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended PGEN as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Precigen Inc (NASDAQ:PGEN) trade information
Instantly PGEN was in green as seen at the end of in last trading. With action 4.44%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 25.89%, with the 5-day performance at 4.44% in the green. However, in the 30-day time frame, Precigen Inc (NASDAQ:PGEN) is 2.92% up.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 76.5% from its current market value. According to analyst projections, PGEN’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -325.53% plunge from its current level, while the stock would need to soar -325.53% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 25.76%. The 2025 estimates are for Precigen Inc earnings to increase by 25.00%.
PGEN Dividends
Precigen Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 4.0604% or 10.25 million shares worth $16.19 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were Advisor Managed Portfolios-Patient Opportunity Trust and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 13.6 shares estimated at $19.18 million under it, the former controlled 4.61% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 1.85% of the shares, roughly 5.45 shares worth around $7.69 million.
